These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9034327)

  • 1. Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas.
    Jonkers J; Korswagen HC; Acton D; Breuer M; Berns A
    EMBO J; 1997 Feb; 16(3):441-50. PubMed ID: 9034327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
    Baxter EW; Blyth K; Cameron ER; Neil JC
    J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Frat1 in transgenic mice leads to glomerulosclerosis and nephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression.
    Jonkers J; Weening JJ; van der Valk M; Bobeldijk R; Berns A
    Oncogene; 1999 Oct; 18(44):5982-90. PubMed ID: 10557087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
    Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.
    Haupt Y; Harris AW; Adams JM
    Oncogene; 1992 May; 7(5):981-6. PubMed ID: 1570158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenesis in transgenic mice: identification and characterization of synergizing oncogenes.
    Berns A
    J Cell Biochem; 1991 Oct; 47(2):130-5. PubMed ID: 1661736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
    Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
    Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EmuMyc transgenic mice.
    Mikkers H; Allen J; Berns A
    Oncogene; 2002 Sep; 21(43):6559-66. PubMed ID: 12242653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of collaborating oncogenes in compound mutant mice.
    Berns A; Mikkers H; Krimpenfort P; Allen J; Scheijen B; Jonkers J
    Cancer Res; 1999 Apr; 59(7 Suppl):1773s-1777s. PubMed ID: 10197595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-myc activation by proviral insertion in MCF 247-induced murine T-cell lymphomas.
    Dolcetti R; Rizzo S; Viel A; Maestro R; De Re V; Feriotto G; Boiocchi M
    Oncogene; 1989 Aug; 4(8):1009-14. PubMed ID: 2548143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.
    Breuer M; Wientjens E; Verbeek S; Slebos R; Berns A
    Cancer Res; 1991 Feb; 51(3):958-63. PubMed ID: 1988138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of lymphoid tumors induced by a recombinant murine retrovirus carrying the avian v-myc oncogene. Identification of novel (B-lymphoid) tumors in the thymus.
    Brightman BK; Chandy KG; Spencer RH; Gupta S; Pattengale PK; Fan H
    J Immunol; 1988 Oct; 141(8):2844-54. PubMed ID: 2902139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma.
    Wotton S; Stewart M; Blyth K; Vaillant F; Kilbey A; Neil JC; Cameron ER
    Cancer Res; 2002 Dec; 62(24):7181-5. PubMed ID: 12499254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
    Feldman BJ; Reid TR; Cleary ML
    Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.
    Zörnig M; Schmidt T; Karsunky H; Grzeschiczek A; Möröy T
    Oncogene; 1996 Apr; 12(8):1789-801. PubMed ID: 8622900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphomagenesis in E mu-myc transgenic mice can involve ras mutations.
    Alexander WS; Bernard O; Cory S; Adams JM
    Oncogene; 1989 May; 4(5):575-81. PubMed ID: 2657573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
    Roland J; Morello D
    Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice.
    Dupressoir A; Heidmann T
    Oncogene; 1997 Jun; 14(24):2951-8. PubMed ID: 9205102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning and expression of proto-oncogene FRAT1 in human cancer.
    Saitoh T; Mine T; Katoh M
    Int J Oncol; 2002 Apr; 20(4):785-9. PubMed ID: 11894125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.